查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1263972

支架的全球市场:趋势，机会，竞争分析(2022年～2027年)

Stent Market: Trends, Opportunities and Competitive Analysis [2022-2027]
出版日期: | 出版商: Lucintel | 英文 181 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球支架的市场规模，2027年成为142亿美元，从2022年到2027年的预测期间内的年复合成长率成为6.5％。介入性心臟学和末稍血管手术增加，缩短高风险传统手术患者的治疗时间的技术进步，促进市场成长。

本报告提供全球支架市场的相关调查，市场动态，市场趋势，企业简介等全面性资讯。

目录

第1章 摘要整理

第2章 市场背景与分类

  • 简介，背景，分类
  • 供应链
  • 产业的推动因素与课题

第3章 市场趋势与预测分析(2016年～2027年)

  • 宏观经济的趋势与预测
  • 全球支架市场趋势与预测
  • 全球支架市场:各产品类型
    • 冠状动脉支架
    • 末梢血管支架
  • 全球支架市场:各技术
    • 传统金属支架
    • 药物释放型血管支架
    • 生物可吸收支架
  • 全球支架市场:各材料
    • 金属
    • 聚合物
  • 全球支架市场:各最终用途

第4章 市场趋势与预测分析:各地区

  • 全球支架市场:各地区
  • 北美的支架市场
  • 欧洲的支架市场
  • 亚太地区的支架市场
  • 其他的支架市场

第5章 竞争的分析

  • 产品系列分析
  • 市场占有率分析
  • 运用整合
  • 地理范围
  • 波特的五力分析

第6章 成本结构分析

  • 销售原价
  • 贩管费
  • EBITDA获利率

第7章 成长机会及策略分析

  • 成长机会分析
    • 全球支架市场成长机会:各产品类型
    • 全球支架市场成长机会:各技术
    • 全球支架市场成长机会:各材料
    • 全球支架市场成长机会:各地区
  • 全球支架市场上新的趋势
  • 策略分析
    • 新产品的开发
    • 全球支架市场生产能力扩大
    • 全球支架市场的合併，收购，合资企业

第8章 主要企业简介

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic Public Limited Company
  • C. R. Bard, Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health Inc.
  • Stryker Corporation
  • Johnson & Johnson
  • Edwards Life Sciences Corporation
简介目录

Stent Market Trends and Forecast

The future of the global stent market looks promising with opportunities in the segments of hospital and ambulatory surgical centers. The global stent market is expected to reach an estimated $14.2 billion by 2027 with a CAGR of 6.5% from 2022 to 2027. The major growth drivers for this market are increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.

Emerging Trends in the Stent Market

Emerging trends which have a direct impact on the dynamics of the market include increasing use of bioreabsorbable stent, increasing adoption of co-polymers as raw materials, and increasing adoption of bifurcated stents.

A total of 83 figures / charts and 74 tables are provided in this 181-page report to help in your business decisions. Sample figures with some insights are shown below.

Stent Market by Segments

In this market, hospital is the largest application market, whereas coronary stent is largest market by product type. Growth in various segments of the stent market is given below:

The study includes a trend and forecast for the stent market by product type, material, technology, end use, and region as follows:

Stent Market by Product Type [Value ($ Million) and Volume (Million Units) from 2016 to 2027]:

  • Coronary Stents
  • Peripheral Vascular Stents

Stent Market By Material [Value ($ Million) and Volume (Million Units) from 2016 to 2027]:

  • Metal
  • Polymer

Stent Market By Technology [Value ($ Million) and Volume (Million Units) from 2016 to 2027]:

  • Bare Metal Stents
  • Drug Eluting Stents
  • Bioreabsorbable Stents

Stent Market by End Use [Value ($ Million)]:

  • Hospital
  • Ambulatory Surgical Center

Stent Market by Region [Value ($ Million) and Volume (Million Units) from 2016 to 2027]:

  • North America

United States

Canada

Mexico

  • Europe

Germany

France

United Kingdom

Italy

Spain

  • APAC

China

India

Japan

  • ROW

Brazil

List of Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stent companies profiled in this report include.

  • Abbott Laboratory
  • Boston Scientific
  • Medtronic public limited company
  • C R Bard
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health

Stent Market Insights

  • Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders.
  • Within the global stent market, the drug eluting stent segment will remain the largest market by technology during the forecast period due to low restenosis rate after surgery. Bioreabsorbable stent is expected to witness the highest growth during the forecast period due to its property of getting absorbed in the body.
  • By material, the global stent market is segmented into metal and polymer. The polymer segment is expected to remain the largest segment in the forecast period.
  • North America is expected to remain the largest market during the forecast period mainly due to its well-developed healthcare infrastructure and continued technological advancements across the healthcare industry.

Features of the Stent Market

  • Market Size Estimates: Stent market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2016-2021) and forecast (2022-2027) by various segments and regions.
  • Segmentation Analysis:Stent market size by various segments, such as product type, material, technology, and end use.
  • Regional Analysis: Stent market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different product type, material, technology, end use, and regions for stent market.
  • Strategic Analysis: This includes M&A and competitive landscape for the stent.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the stent market size?

Answer:The global stent market is expected to reach an estimated $14.3 billion by 2027.

Q2. What is the growth forecast for stent market?

Answer:The stent market is expected to grow at a CAGR of ~6.5% from 2022 to 2027.

Q3. What are the major drivers influencing the growth of the stent market?

Answer: The major growth drivers for this market are increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.

Q4. What are the major applications or end use industries for stent?

Answer:Hospital and Ambulatory Surgical Center are the major end use for stent

Q5. What are the emerging trends in stent market?

Answer:Emerging trends which have a direct impact on the dynamics of the market include increasing use of bioreabsorbable stent, increasing adoption of co-polymers as raw materials, and increasing adoption of bifurcated stents.

Q6. Who are the key stent companies?

Answer:Some of the key stent companies are as follows:

  • Abbott Laboratory
  • Boston Scientific
  • Medtronic public limited company
  • C R Bard
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health

Q7.Which stent product segment will be the largest in future?

Answer: Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders.

Q8. In stent market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region and is expected to witness the highest growth over next 5 years

Q9. Do we receive customization in this report?

Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising potential, high-growth opportunities for the stent market by product type (coronary stent and peripheral vascular stent), material (metal and polymer), technology (bare metal stent, drug eluting stent, and bioreabsorbable stent), end use (hospital and ambulatory surgical center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2 Which segments will grow at a faster pace and why?
  • Q.3 Which regions will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the stent market?
  • Q.5 What are the business risks and threats to the stent market?
  • Q.6 What are emerging trends in this stent market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the stent market?
  • Q.8 What are the new developments in the stent market? Which companies are leading these developments?
  • Q.9 Who are the major players in the stent market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in the stent market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M&A activities did take place in the last five years in the stent market?

Table of Contents

1.Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2016 to 2027

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Stent Market Trends and Forecast
  • 3.3: Global Stent Market by Product Type
    • 3.3.1: Coronary Stent
    • 3.3.2: Peripheral Vascular Stents
  • 3.4: Global Stent Market by Technology
    • 3.4.1: Bare Metal Stents
    • 3.4.2: Drug Eluting Stents
    • 3.4.3: Bioreabsorbable Stents
  • 3.5: Global Stent Market by Material
    • 3.5.1: Metal
    • 3.5.2: Polymer
  • 3.6: Global Stent Market by End Use

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Stent Market by Region
  • 4.2: North American Stent Market
    • 4.2.1 Market by Product Type: Coronary and Peripheral Vascular Stents.
    • 4.2.2 Market by Technology: Bare Metal, Drug Eluting, and Bioreabsorbable Stents.
    • 4.2.3 Market by Material: Metal and Polymer.
    • 4.2.4 United States Stent Market
    • 4.2.5 Mexican Stent Market
    • 4.5.6 Canadian Stent Market
  • 4.3: European Stent Market
    • 4.3.1 Market by Product Type: Coronary and Peripheral Vascular Stents
    • 4.3.2 Market by Technology: Bare Metal, Drug Eluting, and Bioreabsorbable Stent
    • 4.3.3 Market by Material: Metal and Polymer.
    • 4.3.4 German Stent Market
    • 4.3.5 French Stent Market
    • 4.3.6 United Kingdom Stent Maret
    • 4.4.7 Italian Stent Market
    • 4.4.8 Spanish Stent Market
  • 4.5: APAC Stent Market
    • 4.5.1: Market by Product Type: Coronary and Peripheral Vascular Stents.
    • 4.5.2: Market by Technology: Bare Metal, Drug Eluting, and Bioreabsorbable Stents
    • 4.5.3: Market by Material: Metal and Polymer
    • 4.5.4: Japanese Stent Market
    • 4.5.5: Chinese Stent Market
    • 4.5.6: Indian Stent Market
  • 4.6: ROW Stent Market
    • 4.6.1: Market by Product Type: Coronary and Peripheral Vascular Stents
    • 4.6.2: Market by Technology: Bare Metal, Drug Eluting, and Bioreabsorbable Stents
    • 4.6.3:Market by Material: Metal and Polymer
    • 4.6.4: Brazilian Stent Market

5. Competitor Analysis

  • 5.5: Product Portfolio Analysis
  • 5.6: Market Share Analysis
  • 5.7: Operational Integration
  • 5.8: Geographical Reach
  • 5.9: Porter's Five Forces Analysis

6. Cost Structure Analysis

  • 6.1: Cost of Goods Sold
  • 6.2: SG&A
  • 6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis

  • 7.1: Growth Opportunity Analysis
    • 7.1.1: Growth Opportunities for the Global Stent Market by Product Type
    • 7.1.2: Growth Opportunities for the Global Stent Market by Technology
    • 7.1.3: Growth Opportunities for the Global Stent Market by Material
    • 7.1.4: Growth Opportunities for the Global Stent Market by Region
  • 7.2: Emerging Trends in the Global Stent Market
  • 7.3: Strategic Analysis
    • 7.3.1: New Product Development
    • 7.3.2: Capacity Expansion of the Global Stent Market
    • 7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stent Market

8. Company Profiles of Leading Players

  • 8.1: Abbott Laboratories
  • 8.2: Boston Scientific Corporation
  • 8.3: Medtronic Public Limited Company
  • 8.4: C. R. Bard, Inc.
  • 8.5: Cook Medical Inc.
  • 8.6: Terumo Corporation
  • 8.7: Cardinal Health Inc.
  • 8.8: Stryker Corporation.
  • 8.9: Johnson & Johnson
  • 8.10: Edwards Life Sciences Corporation